New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
作者信息
Cairns A P, Duncan M K J, Hinder A E, Taggart A J
机构信息
Department of Rheumatology, Musgrave Park Hospital, Belfast, Northern Ireland, UK.
出版信息
Ann Rheum Dis. 2002 Nov;61(11):1031-2. doi: 10.1136/ard.61.11.1031.
Abstract
摘要
相似文献
1
New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.一名正在接受依那西普治疗类风湿关节炎的患者新发系统性红斑狼疮。
Ann Rheum Dis. 2002 Nov;61(11):1031-2. doi: 10.1136/ard.61.11.1031.
2
Dermatological complications of etanercept therapy for rheumatoid arthritis.类风湿关节炎患者使用依那西普治疗的皮肤并发症
Br J Dermatol. 2002 Feb;146(2):334-5. doi: 10.1046/j.1365-2133.2002.4653_4.x.
3
Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.一名类风湿关节炎患者出现依那西普诱导的狼疮样综合征。
Arthritis Rheum. 2003 Apr;48(4):1165-6; author reply 1166. doi: 10.1002/art.11033.
4
Etanercept-induced systemic lupus erythematosus.依那西普诱发的系统性红斑狼疮。
Clin Exp Dermatol. 2003 Nov;28(6):604-7. doi: 10.1046/j.1365-2230.2003.01411.x.
5
Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.依那西普诱发类风湿关节炎患者发生系统性红斑狼疮。
J Korean Med Sci. 2006 Oct;21(5):946-9. doi: 10.3346/jkms.2006.21.5.946.
6
Etanercept-induced pleuropericardial lupus-like syndrome.
Eur Respir J. 2009 Apr;33(4):939-41. doi: 10.1183/09031936.00182308.
7
Drug-induced systemic lupus erythematosus associated with etanercept therapy.与依那西普治疗相关的药物性系统性红斑狼疮
Lancet. 2002 Feb 16;359(9306):579-80. doi: 10.1016/S0140-6736(02)07714-0.
8
Etanercept-associated SLE with lupus nephritis.与依那西普相关的系统性红斑狼疮伴狼疮性肾炎。
Lupus. 2009 Jun;18(7):667-8. doi: 10.1177/0961203308100560.
9
Diffuse skin reaction after changing the etanercept formulation.更换依那西普制剂后的弥漫性皮肤反应。
Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1165.
10
Etanercept-induced dermatitis in a patient with rheumatoid arthritis.一名类风湿关节炎患者出现的依那西普诱发的皮炎。
J Eur Acad Dermatol Venereol. 2006 May;20(5):614-5. doi: 10.1111/j.1468-3083.2006.01497.x.
引用本文的文献
1
Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.类风湿关节炎中肿瘤坏死因子抑制剂停药研究的系统评价。
Clin Ther. 2013 Nov;35(11):1850-61.e1. doi: 10.1016/j.clinthera.2013.09.015. Epub 2013 Oct 22.
2
Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().抗肿瘤坏死因子-α诱导的系统性红斑狼疮（）
Open Rheumatol J. 2012;6:315-9. doi: 10.2174/1874312901206010315. Epub 2012 Nov 16.
3
Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behçet's disease with infliximab.血清抗核抗体滴度升高与英夫利昔单抗治疗白塞病疗效降低的相关性。
Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1081-7. doi: 10.1007/s00417-011-1908-1. Epub 2012 Jan 11.
4
A randomized, pilot trial of etanercept in dermatomyositis.随机、皮肌炎的依那西普试验
Ann Neurol. 2011 Sep;70(3):427-36. doi: 10.1002/ana.22477. Epub 2011 Jun 17.
5
Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.一名对多种非生物和生物改善病情抗风湿药物不耐受的类风湿关节炎患者对阿那白滞素发生过敏反应。
Ann Pharmacother. 2009 May;43(5):967-72. doi: 10.1345/aph.1L573.
6
The safety of etanercept for the treatment of plaque psoriasis.依那西普治疗斑块状银屑病的安全性。
Ther Clin Risk Manag. 2007 Jun;3(2):245-58. doi: 10.2147/tcrm.2007.3.2.245.
7
Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.抗核小体抗体作为类风湿关节炎中三种不同肿瘤坏死因子α阻断剂治疗期间自身抗体产生的预测因子。
Clin Rheumatol. 2008 Jan;27(1):91-5. doi: 10.1007/s10067-007-0728-5. Epub 2007 Oct 10.
8
[Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].[ASAS/EULAR 之后强直性脊柱炎管理的建议。德语区的评估]
Z Rheumatol. 2006 Dec;65(8):728-42. doi: 10.1007/s00393-006-0119-3.
9
Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.依那西普诱发类风湿关节炎患者发生系统性红斑狼疮。
J Korean Med Sci. 2006 Oct;21(5):946-9. doi: 10.3346/jkms.2006.21.5.946.
10
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.强直性脊柱炎管理的当前证据：针对强直性脊柱炎ASAS/EULAR管理建议的系统文献综述
Ann Rheum Dis. 2006 Apr;65(4):423-32. doi: 10.1136/ard.2005.041129. Epub 2005 Aug 26.
Zotero 插件